UC Davis Health Professor of Psychiatry and Behavioral Sciences David Hessl will help lead a major research project to ...

ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of ...

Major institutional investors have increased their exposure to neurological disorder treatment companies in 2024 and 2025, ...

Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer's Disease ...

Hard bowel movements, pushing too hard, sitting too long, skipping lube or using the wrong kind, toys that are too big — or ...

Neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis, constitute a primary global health ...

LIVERMORE — Lawrence Livermore National Laboratory (LLNL) scientists are making progress with high-performance computing machines, including the supercomputer Tuolumne, and a tailored artificial intel ...

Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women’s childbearing years, even when those drugs have been shown to be safe for use ...

That’s a vital question, because the same fundamental science addresses very different, but equally critical, challenges in ...

No new safety findings were observed in the OLE with continued lecanemab treatment over four years. Rates of amyloid-related imaging abnormalities (ARIA) decreased after the initial 12 months and ...

It was the early 2000s when researchers first showed that exercise can help relieve the tremors that are common with Parkinson's Disease ...

The prodromal period is difficult to detect, but researchers studied people who were at high risk of developing Parkinson’s.